Ghana Medical Journal · 2022 · 11 citations · 28 references
MedicineGynecologyOncologyGynecologic OncologyReproductive HealthWomen's HealthCervical CancerCervical HistologyCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyGynecologic Cancer EpidemiologyCervical Cancer PrevalenceCervical Cancer StagingLate-stage PresentationOutcome MeasuresPaper Questionnaire DesignPrimary Outcome Analysis
Objective: To explore factors associated with late clinical presentation among Ghanaian women with cervical cancer. Design: This is a cross-sectional survey using a paper questionnaire. Setting: Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. Participants: Participants were women presenting for cervical cancer care at KATH. Inclusion criteria were histologically diagnosed cervical cancer and age ≥18 years. The exclusion criteria was age <18. All women presenting from August 2018-August 2019 were recruited. Main outcome measures: The primary outcome was the proportion of participants presenting with late-stage cervical cancer, defined as stage II or higher. Results: Of 351 total participants, 33.6% were unemployed, 35.3% had no formal education, and 96.6% had an average monthly income of less than five hundred Ghana cedis ($86 USD). Time from symptoms to seeing a doctor ranged from fewer than two weeks (16.0%) to more than twelve months (8.6%). Participants' most common barrier in seeking healthcare was financial constraints (50.0%). Most participants presented at late-stage cervical cancer (95.2%, n=334), with only 4.8% (n=17) presenting at stage I. Of participants presenting with late-stage cervical cancer, the vast majority had never had a Papanicolaou (Pap) smear (99.1%) nor a recent gynecologic exam (99.3%). After adjusting for age, parity, and distance to a healthcare facility, a late-stage presentation was associated with lower income and living in a rural area. Conclusions: In Ghana, 95% of women with cervical cancer seek care at a late clinical stage, defined as stage II or greater, when the cancer is inoperable. Funding: None declared.
28
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn, Elisabete Weiderpass, Laia Bruni et al. · The Lancet Global Health · 2019 · 4.1K citations · Full text
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray, Jiansong Ren, E. Masuyer et al. · International Journal of Cancer · 2012 · 1.9K citations · Full text
Neerja Bhatla, Daisuke Aoki, Daya Nand Sharma et al. · International Journal of Gynecology & Obstetrics · 2018 · 1.1K citations · Full text
Medicine, Gynecology, Oncology +6